ArticleCancer medicine2020

Bcl-2/Bcl-xl inhibitor APG-1252-M1 is a promising therapeutic strategy for gastric carcinoma.

Hanjie Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.